Microhydranencephaly

From WikiMD's WELLNESSPEDIA

Microhydranencephaly is a rare neurological disorder that affects the brain's development. This condition is characterized by the combination of microcephaly and hydranencephaly, where the brain's cerebral hemispheres are absent or reduced in size and replaced by sacs filled with cerebrospinal fluid.

Symptoms[edit]

The symptoms of microhydranencephaly can vary greatly among individuals. However, common symptoms include intellectual disability, lack of growth, seizures, and problems with physical coordination. Some individuals may also have distinctive facial features, such as a sloping forehead, large ears, and a small jaw.

Causes[edit]

Microhydranencephaly is caused by disruptions in the normal development of the neural tube, a structure in the developing embryo that eventually becomes the brain and spinal cord. The exact cause of these disruptions is unknown, but it is thought to involve a combination of genetic and environmental factors.

Diagnosis[edit]

Diagnosis of microhydranencephaly is typically made based on the physical symptoms and imaging studies, such as MRI or CT scan, which can reveal the characteristic brain abnormalities. Genetic testing may also be performed to identify any underlying genetic mutations.

Treatment[edit]

There is currently no cure for microhydranencephaly. Treatment is supportive and aimed at managing the symptoms. This may include medications to control seizures, physical therapy to improve motor skills, and special education services to address intellectual disabilities.

Prognosis[edit]

The prognosis for individuals with microhydranencephaly is generally poor, with most individuals not surviving past infancy. However, with appropriate supportive care, some individuals may live into childhood or adolescence.

See also[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.